Pharmacogenomic Testing: Clinical Trials

124 trials of Pharmacogenomic Testing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

70 completed, 17 unknown, 14 terminated, 11 active not recruiting. 37 Not applicable, 30 Phase 2, 25 Phase 1, 9 Phase 3, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable37Completed 20, Recruiting 4, Active not recruiting 3, Terminated 3, Unknown 3, Not yet recruiting 2, Suspended 1, Withdrawn 1
Phase 230Completed 19, Terminated 4, Active not recruiting 3, Unknown 2, Withdrawn 2
Phase 125Completed 17, Terminated 5, Active not recruiting 3
Phase 39Completed 3, Unknown 3, Active not recruiting 2, Terminated 1
Phase 46Unknown 3, Completed 2, Terminated 1

Follow Pharmacogenomic Testing: new trials by email Literature Review of Pharmacogenomic Testing trials Research Report on Pharmacogenomic Testing

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Pharmacogenomic Testing - Pediatric Cancer
Not applicableNot yet recruitingWake Forest University Health Sciences1302026-11-012026-09-25
Biomarkers and Pharmacogenomics for Precision Depression Therapy
Pharmacogenomic Testing, Antidepressant Agents - Depression / Major Depressive Disorder
Not applicableNot yet recruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine2202026-07-012026-07-31
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx" - Cancer, Gastrointestinal Cancer
Not applicableActive not recruitingWake Forest University Health Sciences1202025-07-182026-07-27
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Pharmacogenetic Testing - Mental Disorder, Pharmacogenetics
Not applicableRecruitingUniversity of Manitoba2002025-07-012025-09-08
PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)
Pharmacogenomic testing - Pharmacogenomic Drug Interaction
Not applicableRecruitingNHS Greater Glasgow and Clyde20002025-04-092026-10-19
Pharmacogenomic Informed Statin Prescribing
Pharmacogenetic and polygenic risk testing, Active control - Hypercholesterolemia
Not applicableRecruitingVA Office of Research and Development2142025-04-012026-11-02
Informing Pain Treatment Using Pharmacogenomic Analysis
Pharmacogenomic (PGx) results. - Adult Patients Who Are Receiving Oncologic Care
Not applicableRecruitingUniversity of Chicago8002024-07-302026-05-04
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
Pharmacogenetic testing, Drug-Drug interaction analysis - Nausea With Vomiting Chemotherapy-Induced, Depression, Reactive
RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's6002023-05-012025-07-09
Pharmacogenetic-guided Choice of Post-surgery Analgesics
Pharmacogenetic testing, Pharmacist note with genotype-guided analgesic recommendations, Pharmacist detailed note with genotype-guided recommendations per CPIC guidelines - Acute Pain, Post Operative Pain
Not applicableCompletedUniversity of Pennsylvania1122022-10-132026-04-01
The INTEGRATE Study: Integrated Pharmacogenetics, TDM and Active Pharmacovigilance as Innovative Tools for the Optimisation and Appropriateness of Drug Therapy
Pharmacogenetics, TDM and MedReview - Adverse Drug Reaction (ADR)
Active not recruitingDirezione centrale salute, politiche sociali e disabilità4502022-06-102026-03-12
Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy
Blood samples will be taken for pharmacokinetics and pharmacogenetics - Resistant Arterial Hypertension
Not applicableUnknownRyazan State Medical University1902022-03-112024-04-24
Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting
Pharmacogenomic Testing - Pharmacogenomics, Polypharmacy
UnknownTabula Rasa HealthCare15002021-11-022022-09-02
Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans
Pharmacogenomic Screening - Pharmacogenetics, Depressive Disorder, Major
Not applicableWithdrawnAuburn University2021-09-012022-08-09
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)
Pharmacogenetic testing, Clinical decisions support - Depression
Not applicableCompletedDuke University15722021-08-102025-06-29
Implementation of a Pharmacist-led Pharmacogenomic Clinical Service
Pharmacogenomic Testing - Adverse Drug Event, Drug Drug Interaction
WithdrawnTabula Rasa HealthCare2021-07-012023-02-01
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)
Pharmacogenetic testing, Clinical decisions support - Acute Pain
Not applicableCompletedDuke University16022021-03-102026-03-19
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Chronic Pain Trial)
Pharmacogenetic testing, Clinical decisions support - Chronic Pain
Not applicableCompletedDuke University10482021-02-242025-05-28
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (DCRI Coordinating Center)
Pharmacogenetic testing, Clinical decisions support - Depression, Acute Pain
Not applicableCompletedDuke University42842021-02-242026-03-25
Pharmacogenetic Supported Prescribing in Kids
Pharmacogenetic Testing - Mental Health Impairment
Not applicableActive not recruitingUniversity of Calgary60002021-01-182026-05-12
Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care
Pharmacogenetic Testing, Pharmacist Consultation Note, Delayed pharmacogenetic testing - Chronic Pain
Not applicableUnknownMedstar Health Research Institute3152020-12-022024-03-26

Showing 20 of 124. Sign in to see all of them.

Conditions studied

Depression (13)  ·  Breast Neoplasms (10)  ·  Drug-Related Side Effects and Adverse Reactions (8)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (7)  ·  Depressive Disorder, Major (6)  ·  Lymphoma, B-Cell, Marginal Zone (6)  ·  Lymphoma, Mantle-Cell (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (6)  ·  Colorectal Neoplasms (5)  ·  Lymphoma, Follicular (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Lymphoma, Non-Hodgkin (5)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Psychological Well-Being (5)  ·  Anxiety Disorders (4)

Sponsors

National Cancer Institute (NCI) (22)  ·  Mayo Clinic (6)  ·  Avera McKennan Hospital & University Health Center (5)  ·  Duke University (5)  ·  University of Chicago (4)  ·  Wake Forest University Health Sciences (4)  ·  Children's Oncology Group (3)  ·  University of Nebraska (3)  ·  Case Comprehensive Cancer Center (2)  ·  City of Hope Medical Center (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Genelex Corporation (2)  ·  Institut Cancerologie de l'Ouest (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)  ·  Tabula Rasa HealthCare (2)

Countries

United States (79)  ·  France (11)  ·  Canada (9)  ·  United Kingdom (8)  ·  Belgium (3)  ·  Italy (3)  ·  Australia (2)  ·  China (2)  ·  Egypt (2)  ·  Greece (2)  ·  Netherlands (2)  ·  Russia (2)  ·  Singapore (2)  ·  Slovenia (2)  ·  Spain (2)

Top investigators

Hrishikesh Chakraborty (4)  ·  Patricia LoRusso (3)  ·  Hedy Kindler (2)  ·  Jai Patel, PharmD (2)  ·  James N. Ingle, MD (2)  ·  Matthew Stanley, MD (2)  ·  Todd Skaar, PhD (2)  ·  Abdullah Al Maruf, PhD, M.Pharm., B.Pharm (1)  ·  Adil Bharucha, MBBS, MD (1)  ·  Adriana M Calvo, PhD (1)  ·  Alison Quinn, PharmD (1)  ·  Alvaro Pereira (1)  ·  Amir Mortazavi, MD (1)  ·  An Pang Chieng, MD (1)  ·  Andrea E Wahner Hendrickson (1)

Results publications

PMID 41719044, PMID 42090156, PMID 10440432, PMID 10447337, PMID 10738843, PMID 10797074, PMID 11033734, PMID 11170945, PMID 15342610, PMID 16080072, PMID 16505659, PMID 19017859, PMID 20098694, PMID 21685488, PMID 21880792, PMID 22949583, PMID 23537581, PMID 24100924, PMID 24170610, PMID 24322269, PMID 24909419, PMID 24978045, PMID 25355819, PMID 26182689, PMID 26242208, PMID 26928328, PMID 26943915, PMID 27634566, PMID 27716152, PMID 28151991, PMID 28248319, PMID 28270022, PMID 28411282, PMID 28654574, PMID 28973620, PMID 29954415, PMID 30181415, PMID 30479202, PMID 30784356, PMID 31073101, PMID 31182436, PMID 31365801, PMID 31467059, PMID 31479138, PMID 31486832, PMID 3209527, PMID 33064577, PMID 33205280, PMID 33439748, PMID 33492438

NIH funding

P30CA015083 (5), P30CA022453 (3), U01CA062487 (3), U01HG010225 (3), UM1CA186686 (3), UM1CA186690 (3), UM1CA186691 (3), UM1CA186717 (3), N01CM62201 (2), P30CA014599 (2), P30CA016058 (2), P30CA036727 (2), U01CA062490 (2), U01CA069912 (2), U01CA070095 (2)